- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Finafloxacin 800 mg (as 4 x 200 mg tablet) once daily for 3 days
Total 65 results
-
The George InstituteNational Health and Medical Research Council, AustraliaCompletedChronic Obstructive Pulmonary DiseaseAustralia
-
All India Institute of Medical Sciences, New DelhiCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Hospital for Special Surgery, New YorkCompletedTotal Hip ReplacementUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseNetherlands
-
Medical University of WarsawHuman Biome Institute S.A.Active, not recruitingParkinson DiseasePoland
-
Janssen Pharmaceutical K.K.Completed
-
Brigham and Women's HospitalHarvard School of Public Health (HSPH)Active, not recruitingPneumonia | Asthma | COPD | Pulmonary FunctionUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Vastra Gotaland RegionGöteborg UniversityRecruitingTakotsubo SyndromeNorway, Denmark, Sweden
-
UMC UtrechtNational University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaboratorsRecruitingCommunity-acquired Pneumonia, Influenza, COVID-19United Kingdom, United States, Canada, Australia, Netherlands, Croatia, Germany, Belgium, New Zealand, Ireland, Spain, Japan, Hungary, Colombia, India, Nepal, Pakistan, Portugal, Romania, Saudi Arabia
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | Indolent Non-Hodgkin Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade... and other conditionsUnited States